WNT5A and melanoma: Given that IL-6 positively regulated the Wnt5a expression through the p38α-MAPK pathway in melanoma [78], we draw the reasonable inference that CD146 probably drives melanoma cell motility through the CD146-IL-6-p38α-MAPK- Wnt5a-WRAMP pathway (Figure 4).